EndocrinologyEndocrinology & Diabetic Care

Diabetic Foot (Heberprot-P®)

Heberprot-P® treatment for diabetic foot ulcers, a Cuban-developed epidermal growth factor therapy.

5–8 weeks in Cuba
Ulcer healing in approximately 85% of patients; amputation risk reduced by over 70% success rate
Diabetic Foot Ulcers

About this Treatment

Heberprot-P® is Cuba's recombinant human epidermal growth factor therapy injected into diabetic foot ulcers to accelerate healing and reduce amputation. Used in dozens of countries, it is a cornerstone of Cuba's diabetic foot care, administered by wound-care specialists.

Watch & Learn

Symptoms

Non-healing foot ulcers; deep or infected wounds; tissue necrosis; peripheral neuropathy; reduced limb blood flow; pressure-point calluses; infection signs (redness, pus, odor).

Treatment Benefits

Dramatic amputation-rate reduction; accelerates healing of chronic ulcers; treats deep and complex wounds; internationally evidence-based; improves quality of life; cost-effective versus amputation.

Candidate Criteria

Adults with diabetes and non-healing foot ulcers (Wagner grade ≥2); adequate limb blood supply; no uncontrolled infection requiring immediate surgery. Vascular assessment and wound photos required.

Procedure Overview

1) Wound assessment and grading. 2) Vascular evaluation. 3) Surgical debridement. 4) Intralesional Heberprot-P® (75 µg) every other day. 5) Advanced dressings and offloading. 6) Infection treatment. 7) Monitoring to closure.

Recovery Timeline

Treatment course 5–8 weeks; wound closure in 6–12 weeks; ongoing diabetic management essential.

Risks & Considerations

Local injection-site pain; infection if wound care inadequate; failure in severely ischemic limbs; glycemic management needs attention.

Aftercare & Follow-up

Continued wound care; diabetic foot education; proper footwear and offloading; glycemic control; regular foot exams; lifestyle guidance.

Your Patient Journey

  1. 1

    Consultation

  2. 2

    Wound Assessment

  3. 3

    Vascular Evaluation

  4. 4

    Debridement

  5. 5

    Heberprot-P® Injections

  6. 6

    Monitoring

  7. 7

    Closure & Education

Why Choose Cuba for Diabetic Foot (Heberprot-P®)

Internationally recognized biotechnology

Cuba pioneered breakthroughs like Heberprot-P®, used worldwide for diabetic foot ulcers.

Highly experienced specialists

Board-certified doctors trained in Cuba's acclaimed medical education system.

Affordable all-inclusive packages

From $3,500 (treatment course, all-inclusive)

Personalized patient support

Dedicated coordinators assist you from first inquiry through recovery.

Frequently Asked Questions

Common questions from patients considering this treatment. Still unsure? Contact our team anytime.

Simply fill out the evaluation form on our homepage and our team will review your case within 3-5 business days.